Blog Archives

Personalized medicine is personal – moderator

Personalized medicine is personal – moderator

Cancer, Early Tumor Diagnosis and Tumor DNA moderator

Cancer, Early Tumor Diagnosis and Tumor DNA moderator

2019 GoldLab Symposium Closing Remarks

Welcoming Remarks

Chairman and Founder of GoldLab Foundation; Professor, University of Colorado Boulder; Chairman and Founder of SomaLogic; Founder of NeXstar and Synergen

Cry Havoc

DE-CRUIT® is an interdisciplinary program designed to help military veterans overcome the obstacles of transitioning from military service back into their communities. Countering the military’s intense indoctrination and training, as well as the extreme trauma so commonly experienced as part of military service, DE-CRUIT delivers: a safe, non-judgmental outlet for processing military-related trauma without focusing solely on the trauma or on an assumed pathology within the individual veteran. DE-CRUIT® uses routinized techniques derived from principles of classical actor training (e.g., experiential analysis, symbolic representation, and techniques of breathing and spoken verse) to transform military camaraderie into camaraderie among treatment group members to communalize the process of healing from the trauma of war. The DE-CRUIT® treatment protocol integrates state-of-the-art therapeutic techniques from cognitive science and narrative therapy within a regimen of nutrition, writing, and analyses of trauma as represented by numerous veteran characters in Shakespearian texts. Treatment group members learn to narrate their own stories of trauma through a strengths-based approach that fosters the development of life skills, self-efficacy, and post-traumatic growth.  

Dialogue with Julia and Timothy moderated by Art Krieg, M.D.

Julia Vitarello is founder and CEO of Mila’s Miracle Foundation. Her life has taken her from Washington, D.C., where she grew up, to Amherst College, where she pursued a liberal arts degree, and then to Italy, where she lived and worked for many years

Truly Personalized Medicines for Ultra-Rare Diseases: New Opportunities in Genomic Medicine

Dr. Tim Yu is a neurologist and researcher at Boston Children’s Hospital. A graduate of Harvard College, he completed his M.D. and Ph.D. at UC San Francisco and neurology residency at Massachusetts General Hospital and Brigham and Women’s Hospital.

Why Would Anyone Study Rare Diseases?

Lynne has been a nurse for over 30 years and a Nurse Practitioner working with children and adults who have all types of rare diseases for 25 years.

A Journey into the Science of Mind Over Body

Jo Marchant is an award-winning science journalist and author of several books including the New York Times bestseller Cure: A journey into the science of mind over body (2016).

The Host Cancer Interface: Obesity and Diabetes Promote Cancer Development and May Reduce Treatment Efficacy

Dr. Ann Thor is the Todd Professor and Chair of the Department of Pathology at the University of Colorado School Of Medicine, and the former Rader Professor and Chair of Pathology at the University of Oklahoma Health Sciences Center.